BPC Instruments main ambition is to develop and distribute automated, analytical instruments that allow for a more efficient, reliable, and higher quality research and analysis in the area of low gas volume and flow rate analytical instruments for biotechnology-related applications. The result is significant reductions in time consumption and labor requirement for performing tedious analysis, as well as more efficient use of manpower resources. The business is based on a foundation built on results and experiences by scientists who have created a well-established and IP-protected niche product portfolio. BPC instruments continue to develop new solutions based on innovative ideas. This has enabled the company to continuously become cash flow positive over ten years and establish a client base across near 70 nations.
The company is a pioneer in its field, and the Board of Directors estimates that the company’s current share of the global market of feedstock quality analysis in biogas production equals approx. 90 percent. BPC Instruments has recently expanded towards other biotech business fields including biodegradability of plastics and in-vitro feed analysis for animal farming. The company aims to expand from a single niche market to multiple biotech industrial markets and have a substantial first-mover advantage.
BPC Instruments’ shares are listed on Spotlight Stock Market since December 16, 2021. The shares are traded under the ticker name “BPCINS”, with ISIN code SE0017130826.
* Last updated on MON 9th May 15:00 CET.
The financial figures for 2021 show that we are keeping a solid and stable trend. We see an increasing interest in BPC and our technology, and in 2021 we achieved a record-high turnover for our flagship products Gas Endeavour® and AMPTS® II. Net sales revenue amounted to SEK 26,4 million with a profit before tax of SEK 5,2 million. The net sales of our flagship products surpassed our Q1, H1, Q3, Q4 and H2 2021 expectations. Our annual financial figures show 19,4 % net sales growth meaning BPC has kept the solid and stable trend and demonstrates remarkable growth in the most unstable times.
We will work hard to keep our intelligent analytical instruments as the top choice of universities, research institutes, and service providers worldwide.
BPC Instruments currently operates as a niche player within the biotech analytical instrument sector, taking a small market share from each sector of the larger markets it operates within. We are currently active in the biogas and biodegradability market. BPC Instruments market solutions for a range of applications, including biogas production, animal nutrition, bioplastics and biodegradability, bioethanol production, wastewater treatment, and biohydrogen production.
We assess that the demand for biomethane and liquified biomethane for the biogas market is going to be high due to the recent spike in energy prices and the recently announced European Commission’s plan, REPowerEU. Where increased biogas production has been identified as an essential renewable energy source to phase out dependence on imports of natural gas.
As a pioneer in quality analysis for biogas production, we see excellent business opportunities and increased market potential as the new investments and policies support biogas production. Furthermore, the market demand for instruments of biodegradability analysis is increasing due to new regulations and policies on the elimination of one-time used plastic and reducing pollution in the environment.
To receive press release notifications via email, please enter your email address below.
Please enter your email address below if you do not want to receive email alerts for the subscription listed above. If you do unsubscribe from email alerts, you can subscribe again at any time by using the sign-up process above.